EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Prevalence of high-risk human papillomavirus genotypes among women in Uzbekistan, 2021–2023

Iroda Pulatovna Sharipova iD, Erkin Isakovich Musabaev iD, Shakhlo Sobirovna Sadirova iD, Dildora Tolibjonovna Suyarkulova iD, Shavkat Ekrinovich Tashev iD, Shakhnoza Khayrullaevna Akhmedova iD, Nozimakhon Rakhmatullaxodjaevna Turabova iD, Saidkhon Makhmudkhonovich Sharapov iD, Rano Ibrahimovna Kasimova iD, Ravshan Abdullaevich Rakhimov iD, Guljakhon Toyirovna Yuldashova iD, Kyutaeg Lee iD und 2 weitere

Journal of Gynecologic Oncology · 2025 · 36 (1)

DOI: 10.3802/jgo.2025.36.e7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Gynecologic Oncology, 2025. Verfasst von Iroda Pulatovna Sharipova und 13 weiteren Autor:innen. Beteiligte Einrichtung: Research Institute of Virology, Tashkent, Uzbekistan. Hauptthemen laut MEDLINE: Papillomavirus Infections, Uterine Cervical Neoplasms, Papillomaviridae. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Korea Foundation for International Healthcare.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Cervical cancer remains a significant global health concern. Extensive research has established a critical link between human papillomavirus (HPV) infection and the development of cervical cancer. As a result, high-risk HPV (Hr-HPV) testing has emerged as a promising screening method. This study aimed to retrospectively analyze the prevalence of Hr-HPV genotypes among women in three regions of Uzbekistan. METHODS: Between 2021 and 2023, the Research Institute of Virology of Uzbekistan and the Korea Foundation for International Healthcare conducted a comprehensive population-based study in Tashkent, Andijan, and Samarkand. The study targeted 43,921 women aged 20 and above, utilizing real-time polymerase chain reaction to investigate the prevalence of 12 Hr-HPV genotypes. The analysis included an examination of the distribution of these genotypes based on age, region, and various demographic factors. RESULTS: The overall prevalence of Hr-HPV among women aged 20 and above in Uzbekistan was 7.4%. Regional variations were observed and Hr-HPV prevalence was higher in individuals in their 20s than in other age groups in all 3 regions (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Papillomavirus InfectionsUterine Cervical NeoplasmsPapillomaviridaeHumansFemaleUzbekistanAdultMiddle AgedPrevalenceGenotypeRetrospective StudiesYoung AdultAgedHuman Papillomavirus Viruses

Stichwörter der Autor:innen

GenotypeHigh-Risk Human PapillomavirusMass ScreeningPrevalenceUzbekistan

Autor:innen und Institutionen

  • Research Institute of Virology, Tashkent, Uzbekistan.
  • CAU Medical School, Central Asian University in Tashkent, Tashkent, Uzbekistan.
  • Department of Laboratory Medicine, GC Labs, Yongin, Korea. kyutaeg@gclabs.co.kr.
  • Epidemiology & Statistics Team, Infectious Diseases Research Center, GC Labs, Yongin, Korea. forjund@gclabs.co.kr.
  • Strategy & Planning Unit, GC Labs, Yongin, Korea.
  • Program of Global Health, Department of Public Health, Korea University College of Medicine, Seoul, Korea. hyunwonkim@gclabs.co.kr.

ORCID-Profile: Iroda Pulatovna Sharipova, Erkin Isakovich Musabaev, Shakhlo Sobirovna Sadirova, Dildora Tolibjonovna Suyarkulova, Shavkat Ekrinovich Tashev, Shakhnoza Khayrullaevna Akhmedova, Nozimakhon Rakhmatullaxodjaevna Turabova, Saidkhon Makhmudkhonovich Sharapov, Rano Ibrahimovna Kasimova, Ravshan Abdullaevich Rakhimov, Guljakhon Toyirovna Yuldashova, Kyutaeg Lee, Gayoung Chun, Hyunwon Kim

Förderung

  • Korea Foundation for International Healthcare

Zitieren

APA

Sharipova, I. P., Musabaev, E. I., Sadirova, S. S., Suyarkulova, D. T., Tashev, S. E., Akhmedova, S. K., Turabova, N. R., Sharapov, S. M., Kasimova, R. I., Rakhimov, R. A., Yuldashova, G. T., Lee, K., Chun, G., & Kim, H. (2025). Prevalence of high-risk human papillomavirus genotypes among women in Uzbekistan, 2021–2023. Journal of Gynecologic Oncology, 36(1). https://doi.org/10.3802/jgo.2025.36.e7

Vancouver

Sharipova IP, Musabaev EI, Sadirova SS, Suyarkulova DT, Tashev SE, Akhmedova SK, et al. Prevalence of high-risk human papillomavirus genotypes among women in Uzbekistan, 2021–2023. Journal of Gynecologic Oncology. 2025;36(1). doi:10.3802/jgo.2025.36.e7

BibTeX
@article{Sharipova2025,
  author = {Sharipova, Iroda Pulatovna and Musabaev, Erkin Isakovich and Sadirova, Shakhlo Sobirovna and Suyarkulova, Dildora Tolibjonovna and Tashev, Shavkat Ekrinovich and Akhmedova, Shakhnoza Khayrullaevna and Turabova, Nozimakhon Rakhmatullaxodjaevna and Sharapov, Saidkhon Makhmudkhonovich and Kasimova, Rano Ibrahimovna and Rakhimov, Ravshan Abdullaevich and Yuldashova, Guljakhon Toyirovna and Lee, Kyutaeg and Chun, Gayoung and Kim, Hyunwon},
  title = {Prevalence of high-risk human papillomavirus genotypes among women in Uzbekistan, 2021–2023},
  journal = {Journal of Gynecologic Oncology},
  year = {2025},
  volume = {36},
  number = {1},
  doi = {10.3802/jgo.2025.36.e7}
}
Kostenlos starten →